Corvus Pharmaceuticals

parachute snow mountains
Biotech

Takeda welcomes new oncology chief from CRISPR—Chutes & Ladders

Ex-CRISPR Tx CMO lands at Takeda. Lexeo adds Pfizer rare disease leader as development chief. Merck & Co. leader to join Cartography.
Max Bayer , Gabrielle Masson Feb 9, 2024 9:30am
change direction new plan alter arrows move reprioritize

Corvus pauses plans to start eczema trial to focus on cancer

Mar 29, 2023 9:55am
Newspapers

EuroBiotech:​​​ ​​​More​​​ ​​​Articles​​​ ​​​of​​​ ​​​Note

Feb 16, 2017 9:22am